Clinical Trial Update: Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liposomal doxorubicin and gemcitabine in women with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Pharmatech Oncology | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN